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Abstract
Introduction: Mechanical ventilation (MV) can provoke oxidative stress and an inflammatory response, and
subsequently cause ventilator-induced lung injury (VILI), a major cause of mortality and morbidity of patients in the
intensive care unit. Inhaled hydrogen can act as an antioxidant and may be useful as a novel therapeutic gas. We
hypothesized that, owing to its antioxidant and anti-inflammatory properties, inhaled hydrogen therapy could
ameliorate VILI.
Methods: VILI was generated in male C57BL6 mice by performing a tracheostomy and placing the mice on a
mechanical ventilator (tidal volume of 30 ml/kg without positive end-expiratory pressure, FiO2 0.21). The mice were
randomly assigned to treatment groups and subjected to VILI with delivery of either 2% nitrogen or 2% hydrogen
in air. Sham animals were given same gas treatments for two hours (n = 8 for each group). The effects of VILI
induced by less invasive and longer exposure to MV (tidal volume of 10 ml/kg, 5 hours, FiO2 0.21) were also
investigated (n = 6 for each group). Lung injury score, wet/dry ratio, arterial oxygen tension, oxidative injury, and
expression of pro-inflammatory mediators and apoptotic genes were assessed at the endpoint of two hours using
the high-tidal volume protocol. Gas exchange and apoptosis were assessed at the endpoint of five hours using the
low-tidal volume protocol.
Results: Ventilation (30 ml/kg) with 2% nitrogen in air for 2 hours resulted in deterioration of lung function,
increased lung edema, and infiltration of inflammatory cells. In contrast, ventilation with 2% hydrogen in air
significantly ameliorated these acute lung injuries. Hydrogen treatment significantly inhibited upregulation of the
mRNAs for pro-inflammatory mediators and induced antiapoptotic genes. In the lungs treated with hydrogen,
there was less malondialdehyde compared with lungs treated with nitrogen. Similarly, longer exposure to
mechanical ventilation within lower tidal volume (10 mg/kg, five hours) caused lung injury including bronchial
epithelial apoptosis. Hydrogen improved gas exchange and reduced VILI-induced apoptosis.
Conclusions: Inhaled hydrogen gas effectively reduced VILI-associated inflammatory responses, at both a local and
systemic level, via its antioxidant, anti-inflammatory and antiapoptotic effects.
Introduction
Although ventilatory support is often required in the
intensive care unit (ICU) for the treatment of critically
ill patients with respiratory failure (including acute
respiratory distress syndrome, pneumonia, septic shock,
trauma, aspiration of vomit, and chemical inhalation),
mechanical ventilation (MV) itself can induce lung
injury and worsen preexisting lung injury depending on
the setting and the length of ventilation [1,2]. This con-
dition has been recognized as ventilator-induced lung
injury (VILI). Despite recent progress in reducing the
time on MV (for example, earlier weaning and extuba-
tion) and improving safety of MV (for example, lung
protective ventilation with lower tidal volume), VILI
remains a major concern in the ICU and can lead to
remote organ dysfunction and multiple organ failure [3].
Multifactorial etiologies of VILI, from either direct or
indirect injury to the lung, are postulated [4]. MV with
high tidal volumes and pressure can lead to increased
alveolar-capillary permeability accompanied by the
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release of pro-inflammatory mediators by the lung cells
in response to mechanical stretch. These stimuli trigger
detachment of endothelial cells from the basement mem-
brane and synthesis of extracellular matrix components
[5,6]. Injurious MV also promotes alveolar coagulopathy
and fibrin deposition within the airways [7]. In addition,
generation of reactive oxygen species (ROS) during VILI
causes direct cellular injury and triggers ROS-sensitive,
aberrant activation of cellular mechanisms leading to
severe inflammation, resulting in rapid transcription of
pro-inflammatory cytokines and chemokines [8,9].
Adjunctive therapy with inhaled therapeutic medical
gas is promising and might be reasonable for lung dis-
ease as it would be an easily delivered and straightfor-
ward therapeutic option [10]. Hydrogen, recently
discovered to be a novel therapeutic medical gas in a
variety of biomedical fields, has potent antioxidant and
anti-inflammatory efficacies by eliminating toxic ROS
[11-14]. However, to our knowledge, hydrogen therapy
has not been tested in the VILI setting. Though highly
flammable, hydrogen is safe in concentrations of less
than 4.6% when mixed with air and at concentrations of
less than 4.1% when mixed with oxygen [15]. In this
study, we investigated the hypothesis that, owing to its
antioxidant and anti-inflammatory properties, inhaled
hydrogen therapy could ameliorate VILI.
Materials and methods
Animals
Male wild-type C57BL6 mice (10 to 12 weeks old, 25 to
30 g) were purchased from The Jackson Laboratory (Bar
Harbor, ME, USA). All animals were maintained in
laminar flow cages in a specific pathogen-free facility at
the University of Pittsburgh. The experimental protocol
was approved by the Institutional Animal Care and Use
Committee of the University of Pittsburgh, and all
experiments were performed in adherence to the
National Institutes of Health guidelines for the use of
laboratory animals.
Lung injury model
Mice were anesthetized by intraperitoneal injections of
85 mg/kg ketamine and 15 mg/kg xylazine. Then, under
sterile conditions, a tracheostomy was performed with a
20-gauge angiocatheter which was sutured in place.
Mice were placed in a supine position on a warming
device and then connected to a ventilator (Harvard
Apparatus, Holliston, MA, USA) on volume-control
mode at a constant inspiratory flow. MV was initiated
with a tidal volume of 30 mL/kg or 10 mL/kg (without
an end-expiratory pressure) at a respiratory rate of 120
breaths per minute [16,17]. Mean arterial blood pressure
was continuously monitored via catheterization of a
femoral artery by means of a blood pressure monitor
(Cardiomax III; Columbus Instruments, Columbus, OH,
USA). Mice received intravenous injection of 0.05 mL/
hour saline as well as intraperitoneal ketamine and
xylazine to maintain the blood pressure at 75 to 80 mm
Hg. At the end of the experiment, the animal was eutha-
nized with 150 mg/kg ketamine intraperitoneally.
Experimental design
Mice were randomly assigned to one of four experimen-
tal groups: MV (tidal volume 30 mL/kg, fraction of
inspired oxygen [FiO2] 0.21, 2 hours) with 2% nitrogen in
air (Praxair, Inc., Danbury, CT, USA), MV with 2%
hydrogen in air (Praxair, Inc.), sham controls exposed to
2% nitrogen, or sham controls exposed to 2% hydrogen
(n = 8 for each group). The concentration of 2% hydro-
gen was determined on the basis of previous observations
as an optimal and safe concentration [11,18]. Mice under
ventilation received the therapeutic (2% hydrogen) or
control (2% nitrogen) gases via the tracheal tube. Animals
in the sham groups were given therapeutic gases for
2 hours by means of a gas chamber [19] and underwent
anesthesia only prior to sacrifice and procurement of tis-
sue. While under anesthesia, the control mice received
hydrogen or nitrogen through a face mask by sponta-
neous respiration. In separate experiments, mice were
subjected to MV with a lower tidal volume for a longer
period (10 mL/kg, FiO2 0.21, 5 hours) with 2% nitrogen
or hydrogen in air (n = 6 for each group). At sampling,
after the right lung was isolated and tied off with a
microclamp at the right bronchus, the left lung was used
for bronchoalveolar lavage (BAL). The right lower lobe
was used for wet-to-dry (W/D) ratio measurement, the
right middle lobe was used for histologic examination,
and the other portions of the right lung were immediately
snap-frozen in liquid nitrogen for further experiments,
including gene expression analyses.
Bronchoalveolar lavage
The left lung was used for BAL via slow intratracheal
injection of three sequential 0.5-mL aliquots of sterile
normal NaCl. Cell pellets obtained by centrifuging BAL
samples at 1,500 rpm for 5 minutes at 4°C were resus-
pended in 1 mL of phosphate-buffered saline. The cell
viability was determined via trypan blue exclusion assay.
In brief, 10 μL of cells was mixed with 10 μL of 0.4%
trypan blue and loaded onto a hemocytometer. Protein
concentration in the bronchoalveolar lavage fluid
(BALF) was measured with bovine IgG as a standard as
previously described [20].
Histopathological, immunohistochemistry, and
TUNEL staining
For histologic evaluation, the right middle lobes of the
lungs were fixed in 10% formalin, embedded in paraffin,
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sectioned to 6 μm in thickness, and stained with
hematoxylin and eosin. The slides were blindly reviewed
by one of the authors (NT) without knowledge of
experimental groups (n = 6 for each group). Acute lung
injury was scored according to the following four items:
alveolar congestion, hemorrhage, infiltration or aggrega-
tion of neutrophils in the airspace or the vessel wall,
and thickness of the alveolar wall/hyaline membrane
formation [21]. For analysis of macrophage infiltration,
formalin-fixed, paraffin-embedded mouse lung sections
(4 μm) were deparaffinized and underwent antigen
unmasking with an appropriate buffer. After protein
blocking (DakoCytomation, Carpinteria, CA, USA) for
15 minutes, rat anti-mouse F4/80 primary antibody
(clone: CI:A3-1; AbD Serotec, Raleigh, NC, USA) was
applied and incubated overnight at 4°C. After blocking
endogenous peroxidase, biotinylated goat anti-rat sec-
ondary antibodies (Jackson ImmunoResearch Labora-
tories, Inc., West Grove, PA, USA) were applied
followed by ABC Elite reagent (Vector Laboratories,
Burlingame, CA, USA). Staining was developed with
AEC chromogen (ScyTek Laboratories, Inc., Logan, UT,
USA), and the tissue was counterstained with hematoxy-
lin. The TUNEL (terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate nick-end labeling)
method was used for identification of bronchiolar cell
apoptosis with the ApopTag Peroxidase Kit (Intergen
Co., Purchase, NY, USA). TUNEL-positive bronchial
epithelial cells in five random, high-power fields per sec-
tion were counted with the samples’ identities masked.
Arterial blood analysis
At the end of the experiment, arterial blood was
obtained from the abdominal aorta. Blood gas analyses
and measurement of lactate concentration were per-
formed by means of an iSTAT handheld device (Abaxis,
Union City, CA, USA).
Wet-to-dry weight ratio
The right lower lobe was weighed immediately after col-
lection and placed into a 60°C oven to dry for 2 days.
The dried tissue was weighed to determine the W/D
weight ratio.
Real-time RT-PCR and tumor necrosis factor-alpha
enzyme-linked immunosorbent assay
Since one of the underlying mechanisms of VILI is the
release of pro-inflammatory mediators by the lung cells
and airway epithelial cell apoptosis in response to
mechanical stretch, quantitative real-time reverse tran-
scription-polymerase chain reaction (RT-PCR) for
inflammatory mediators was conducted on RNA
extracted from the lung tissues. The mRNAs for early
growth response-1 (Egr-1), chemokine (CC motif) ligand
2 (CCL2), interleukin (IL)-1b, tumor necrosis factor-
alpha (TNFa), B-cell lymphoma-2 (Bcl-2), Bcl-xL (B-cell
lymphoma-extra large), Bax (B-cell lymphoma-2-
associated X-protein), and b-actin were quantified in
duplicate by means of SYBR Green two-step, real-time
RT-PCR as previously described [13]. The levels of
serum TNF-a were detected by specific enzyme-linked
immunosorbent assay (Thermo Scientific, part of
Thermo Fisher Scientific Inc., Waltham, MA, USA) in
accordance with the manufacturer’s protocol.
Malondialdehyde measurement
Oxidative injury from VILI was determined by measur-
ing the tissue concentration of malondialdehyde (MDA),
a marker of lipid peroxidation, by means of the MDA-
586 kit (OxisResearch; Percipio Biosciences, Inc., Foster
City, CA, USA) in accordance with the manufacturer’s
instructions.
Statistical analysis
Results are presented as mean ± standard deviation. The
EZAnalyze add-in for Microsoft Excel (Microsoft Cor-
poration, Redmond, WA, USA) was used to perform
analysis of variance with an F test and Bonferroni post
hoc group comparisons. After the application of a log
transformation to the data, Bartlett’s test of homogeneity
was not significant and comparison boxplots indicated
that the assumption of constant variance was not vio-
lated. Nonetheless, in cases of possible heterogeneity, an
analysis was performed on the log-transformed data.
Histopathological score was analyzed with a Kruskal-
Wallis test with post hoc Steel-Dwass test for group
comparisons. A P value of less than 0.05 was considered
statistically significant.
Results
Lung injury after mechanical ventilation with high tidal
volume
To evaluate the magnitude of lung injury by MV, sequen-
tial blood gas analysis of arterial blood from the mice
exposed to 2% nitrogen via the ventilator was performed.
Ventilator support improved gas exchange for the first
1 hour, while inhibition of gas exchange was seen in the
animals at the beginning of MV because of muscle
relaxation by general anesthesia. Subsequently, partial
pressure of arterial oxygen (PaO2) gradually decreased
with time in the ventilated mice and the partial pressure
of arterial carbon dioxide (PaCO2) increased, suggesting
that MV with high tidal volume provoked lung damage,
related to alveolar overdistension or volutrauma, in a
time-dependent manner (Figure 1a). To determine
whether hydrogen inhalation affected hemodynamics, we
monitored blood pressure and heart rate under MV. One
hour after the start of MV, there was a significant
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Figure 1 Sequential blood gas analysis of mice exposed to mechanical ventilation with high tidal volume (30 mL/kg). (a) The impact of
mechanical ventilation with 2% nitrogen in air on the lungs in a time-dependent manner was investigated. Animals showed deteriorated gas
exchange before ventilation (0 hour) because of respiratory insufficiency caused by general anesthesia. Although mechanical ventilation
improved gas exchange for the first hour, partial pressures of arterial oxygen (PaO2) were decreased with time and partial pressure of arterial
carbon dioxide (PaCO2) increased with time. N = 3 to 6 for each time point. (b) Blood gas analysis for arterial blood after the end of 2 hours of
mechanical ventilation with high tidal volume. There was improved pulmonary function in mice exposed to ventilator-induced lung injury (VILI)
for 2 hours under 2% hydrogen compared with nitrogen controls. N = 8 for each group. *P < 0.05 versus VILI 30 minutes/N2 and VILI 30
minutes/H2;
#P < 0.05 versus VILI 2 hours/N2.
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decrease in mean arterial pressure in the mice ventilated
with 30 mL/kg of tidal volume. There was no significant
difference in hemodynamics between the VILI/N2 and
VILI/H2 treatment groups over the 2-hour period.
Inspiratory pressure was continuously monitored. Peak
inspiratory pressure of the mice ventilated with 30 mL of
tidal volume was 26.2 ± 0.7 cm H2O, which remained at
constant levels throughout the experiment regardless of
exposure to nitrogen or hydrogen.
Gas exchange during ventilator-induced lung injury
Although the effects of MV with either 2% nitrogen or
2% hydrogen in air using a tidal volume of 30 mL/kg for
30 minutes on lung function were negligible, VILI was
induced by 2 hours of ventilation with 2% N2 in air with
a tidal volume of 30 mL/kg, as indicated by a significant
decrease in PaO2 and an increase in PaCO2. Ventilation
with 2% hydrogen in air exerted protective effects on
the lungs and improved oxygenation of the arterial
blood (Figure 1b). There was no statistical difference in
PaCO2 levels among the groups. The blood pH did not
differ between the 30-minute and 2-hour time points
nor did it differ between the treatment groups (VILI/N2
for 30 minutes, blood pH 7.25 ± 0.05; VILI/H2 for
30 minutes, pH 7.28 ± 0.06; VILI/N2 for 2 hours, pH
7.24 ± 0.04; and VILI/H2 for 2 hours, 7.25 ± 0.05).
Ventilator-induced lung injury-induced pulmonary edema
MV exacerbated pulmonary inflammation and injury, as
indicated by thickening of the alveolar septum and infil-
tration of inflammatory cells, evident in histopathologi-
cal examination. In the presence of hydrogen, both
edema and inflammatory cell infiltration were reduced
despite exposure to MV with a 30 mL/kg tidal volume
(Figure 2a) and the lung injury score was significantly
improved with hydrogen inhalation (Table 1). Two
hours of MV with high tidal volume (2% N2 in air) sig-
nificantly increased the lung W/D ratio compared with
lungs of sham mice. Ventilation with 2% hydrogen in air
ameliorated ventilator-induced edema, as indicated by a
significant decrease in lung W/D ratio as compared with
ventilation with 2% N2 in air (Figure 2b).
Lung lipid peroxidation
Although there were increased MDA-protein adducts in
the lung ventilated with a high tidal volume of 2% nitro-
gen in air, ventilation with 2% hydrogen reduced tissue
MDA levels after 2 hours of MV with high tidal volume
(Figure 2c).
Alveolar-capillary leak due to ventilator-induced lung
injury
MV with 30 mL/kg tidal volume caused an acute exuda-
tive phase with alveolar-capillary leak in conjunction
with leukocyte extravasation and resulted in an increase
in the total cell number in the BALF. The effects of
hydrogen on total cells or protein concentration in the
BALF were marginal (Figure 3a, b). While blood lactate
levels increased in ventilated mice receiving 2% nitrogen,
they did not increase in mechanically ventilated mice
receiving 2% hydrogen in air (Figure 3c).
Expression of inflammatory mediators and apoptosis-
related genes
VILI after ventilation with 2% nitrogen resulted in upre-
gulation of mRNAs for Egr-1, TNFa, IL-1b, and CCL2.
Hydrogen administration significantly attenuated the
upregulation of the mRNAs for these inflammatory
mediators (Figure 4). Hydrogen inhalation increased the
expression of antiapoptotic genes, such as Bcl-2 and Bcl-
xL, and reduced VILI-induced expression of the pro-
apoptotic Bax gene (Figure 5). There was no significant
difference in mRNA expression for the housekeeping
gene b-actin among the groups (data not shown).
Ventilator-induced lung injury with lower tidal volume
Finally, we analyzed whether hydrogen therapy could also
attenuate VILI induced using a less invasive protocol
with longer exposure to MV of lower tidal volume. Indu-
cing VILI in the mice via a tidal volume of 10 mL/kg for
5 hours resulted in deterioration of gas exchange in mice
receiving 2% nitrogen with an associated increase in
pulmonary edema. These lung injuries were significantly
attenuated by treatment with 2% hydrogen (Figure 6a, b).
Hydrogen treatment significantly reduced serum TNFa
concentrations as compared with the serum levels of
TNFa in mice with VILI caused by ventilation with 2%
nitrogen (Figure 6c).
In this VILI model with lower tidal volume, hydrogen
treatment significantly decreased macrophage infiltra-
tion, as determined by F4/80 staining, as compared with
lungs ventilated with 2% nitrogen (Figure 7a, c). MV
with 2% nitrogen also increased apoptotic cell death of
bronchial epithelial cells, as determined by TUNEL.
Ventilation with 2% hydrogen significantly reduced
TUNEL-positive epithelial cells as compared with venti-
lation with 2% nitrogen (Figure 7b, c).
Discussion
In this study, we demonstrated that administration of
hydrogen gas mitigated VILI and VILI-associated oxida-
tive and inflammatory responses as well as VILI-induced
apoptotic cell death of bronchial epithelial cells. To our
knowledge, this is the first study to demonstrate that
hydrogen gas significantly reduces VILI. Since VILI is a
major concern with intensive care, approaches to mini-
mize VILI will advance critical care medicine and could
have substantial clinical impact.
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Figure 2 Lung sections with mechanical ventilation with high tidal volume (30 mL/kg), stained with hematoxylin and eosin.
(a) Alveolar septal thickening and inflammatory cell infiltration were observed in the lung with ventilator-induced lung injury (VILI) (2% N2).
Hydrogen administration markedly reduced these histopathological changes. Magnification = 400 ×. Representative images are shown. N = 6
animals for each experimental group. (b) Wet-to-dry (W/D) ratio of the lungs with mechanical ventilation with high tidal volume (30 mL/kg). VILI
for 2 hours was accompanied with an increase of W/D ratio; ventilation with 2% hydrogen still induced lung edema but to a lesser extent
compared with mechanical ventilation with 2% nitrogen in air. N = 6 for each group. (c) Tissue malondialdehyde (MDA) levels. Mechanical
ventilation with high tidal volume (30 mg/kg) with 2% nitrogen in air increased tissue MDA levels. The supplementation of hydrogen
significantly lowered levels of tissue MDA, a marker of lipid peroxidation. N = 6 for each group. *P < 0.05 versus sham/N2 and sham/H2;
#P <
0.05 versus VILI/N2.
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Recently, the biological functions of therapeutic gases
have received considerable attention and hydrogen was
identified as a physiologically relevant gaseous signaling
molecule like other endogenously generated gases,
including nitric oxide (NO), carbon monoxide, and
hydrogen sulfide [22-24]. Thus, hydrogen has been
described as ‘the fourth signaling gaseous molecule’ [25].
Hydrogen has great potential as a safe and potent
therapeutic medical gas as well as several potential
advantages as a therapeutic option for VILI. Inhalation
therapy is a straightforward approach to lung disease
and can be administered by simply providing gas for the
patient to inhale. Hydrogen may be relatively easily
incorporated into our current interventional or surgical
procedures without increasing their complexity. Inhaled
hydrogen gas has been safely used for treatment of
decompression syndrome in divers [26], suggesting that
hydrogen can be safely administered to patients. Hydro-
gen is a stable molecule and does not react with other
therapeutic medical gases at room temperature and thus
may be administered as a combined gas with other ther-
apeutic gases or inhaled anesthesia agents [18]. Hydro-
gen does not alter NO levels [11]. Endogenous NO
signaling pathways are critical for modulating pulmon-
ary vascular tone and leukocyte/endothelial interactions;
therefore, it may be beneficial to spare endogenous NO
[27]. Hydrogen treatment does not eliminate superoxide
anion (O2
-) or hydrogen peroxide (H2O2) [11]. O2
- and
H2O2 have important functions in neutrophils and
macrophages, allowing phagocytosis. Hydrogen therapy
may spare the innate immune system, and this would be
beneficial because lung infection accompanies VILI in
many cases [28].
Importantly, experimental studies have demonstrated
the protective effects of hydrogen for septic shock [29],
brain injury [11], liver injury [12], ischemic heart disease
[30], and paralytic ileus [13]. As all of these diseases fre-
quently coincide with VILI in ICU patients, inhaled
hydrogen therapy by simply delivering the gas through
the ventilator could be a very promising adjunctive ther-
apy in the ICU or operating room.
In our study, hydrogen inhalation ameliorated upregu-
lation of the mRNAs for TNFa, IL-1b, Egr-1, and CCL2
after 2 hours of MV, and this may explain the anti-
inflammatory mechanisms afforded by hydrogen in this
VILI model. Egr-1 acts as a key pro-inflammatory regu-
lator in VILI. Hoetzel and colleagues [31] demonstrated
that Egr-1-deficient mice did not sustain lung injury
after ventilation, relative to wild-type mice. The CC che-
mokine family is essential for the leukocyte recruitment
during inflammation. Mounting evidence suggests that
CCL2, a member of the CC chemokine family, is
involved in numerous inflammation disorders of the
lung, including VILI [32]. Pro-inflammatory cytokines,
such as TNFa and IL-1b, are elevated and play pivotal
roles during the pathogenesis of VILI [33].
In our model, the increase in W/D ratio because of
MV was relatively mild, despite the larger changes
observed in lung function (gas exchange). The histo-
pathology changes were moderate. We are unsure of the
reason for these discrepancies, although perhaps W/D
ratio is a very sensitive method to detect lung edema
and a small difference of W/D ratio may represent sig-
nificant edema. The gravimetric measure of lung edema
poses considerable technical challenges, including eva-
porative loss and regional heterogenesity. W/D can be
complicated by the inclusion of blood in the wet lung
weight from both residual intravascular blood and blood
introduced into the lung interstitium via bleeding or
injury [34]. In addition, extravasated protein can contri-
bute to total lung weight. Although there are mis-
matches in magnitude of lung injury depending on
which parameter is evaluated, each evaluation is scienti-
fically sound and each indicates some degree of VILI
that was ameliorated by hydrogen treatment.
VILI has been shown to induce apoptosis of airway
epithelial cells [35]. We demonstrated, in the present
study, that hydrogen could upregulate antiapoptotic
genes, including Bcl-2 and Bcl-xL. Although our findings
do not explain all of the mechanisms underlying the
protective effects of hydrogen, we postulate that the Bcl-
2/Bcl-xL pathway might be one of the key mechanisms.
Table 1 Lung injury scores after 2 hours of ventilator-induced lung injury (30 mL/kg)
Lung injury score
Group Treatment Alveolar congestion Hemorrhage Infiltration of neutrophils Alveolar wall thickness Total score
Sham N2 0.25 ± 0.50 0 0.50 ± 0.58 0 0.75 ± 0.50
Sham H2 0.25 ± 0.50 0 0.25 ± 0.50 0 0.50 ± 0.58
VILI N2 1.75 ± 0.50 0 1.75 ± 0.96 1.50 ± 0.58 5.0 ± 1.63*
VILI H2 0.75 ± 0.50 0 1.50 ± 0.57 0.75 ± 0.50 3.0 ± 0.82
Data are presented as mean ± standard deviation (* P < 0.05 versus ventilator-induced lung injury [VILI]/N2). Acute lung injury was scored in each sample (n = 6
for each group) according to the following four items: alveolar congestion, hemorrhage, infiltration or aggregation of neutrophils in airspace or the vessel wall,
and thickness of the alveolar wall/hyaline membrane formation. Each item was graded according to a 5-point scale: 0, minimal (little) damage; 1, mild damage; 2,
moderate damage; 3, severe damage; and 4, maximal damage.
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Figure 3 Number of infiltrating cells recovered in the bronchoalveolar lavage fluid (BALF) obtained from the lungs with mechanical
ventilation with higher tidal volume (30 mL/kg). (a) Administration of hydrogen had no effect on inflammatory cell accumulation in the
BALF. N = 6 for each group. #P < 0.05 versus sham/N2 controls. (b) Protein concentration in BALF. Ventilator-induced lung injury (VILI) resulted in
significant increases of protein contained in BALF. Hydrogen did not reduce leaked protein. N = 6 for each group. (c) Blood lactate
concentration. VILI by mechanical ventilation for 2 hours was associated with hyperlactatemia. Mice subjected to ventilation with 2% hydrogen
did not show significant increase of blood lactate levels compared with those of sham controls. N = 6 for each group. *P < 0.05 versus sham/N2
and sham/H2;
#P < 0.05 versus VILI/N2.
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Figure 4 Quantitative reverse transcription-polymerase chain reaction for inflammatory mediators and transcripts in lung tissues with
mechanical ventilation with higher tidal volume (30 mL/kg). The levels of mRNAs for early growth response-1 (Egr-1) (a), tumor necrosis
factor-alpha (TNFa) (b), interleukin-1-beta (IL-1b) (c), and CCL-2 (d) significantly increased after mechanical ventilation with either with 2%
nitrogen in air (VILI/N2) or 2% hydrogen in air (VILI/H2). However, mRNA expression was significantly less in the VILI/H2 group compared with the
VILI/N2 group. All values are reported as percentage of b-actin with normalization to b-actin mRNA expression. N = 8 for each group. *P < 0.05
versus sham/N2 and sham/H2;
#P < 0.05 versus VILI/N2. CCL2, chemokine (CC motif) ligand 2; VILI, ventilator-induced lung injury.
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Figure 5 Quantitative reverse transcription-polymerase chain reaction for apoptosis-related genes in lung tissues with mechanical
ventilation of higher tidal volume (30 mL/kg). The levels of mRNAs for Bcl-2 (a) and Bcl-xL (b) significantly increased after mechanical
ventilation in the presence of 2% hydrogen in air (VILI/H2). On the other hand, Bax (c) was significantly increased after mechanical ventilation
with 2% nitrogen in air (VILI/N2) and was not increased after mechanical ventilation with 2% hydrogen in air. All values are reported as
percentage of b-actin with normalization to b-actin mRNA expression. N = 6 for each group. *P < 0.05 versus sham/N2 and sham/H2;
#P < 0.05
versus VILI/N2. Bcl-2, B-cell lymphoma-2; Bcl-xL, B-cell lymphoma-extra large; VILI, ventilator-induced lung injury.
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Figure 6 The effects of hydrogen on ventilator-induced lung injury (VILI) induced by mechanical ventilation with low tidal volume
(TV) (10 mL/kg). (a) Partial pressure of arterial oxygen (PaO2) levels of mice ventilated with 2% hydrogen for 5 hours were significantly higher
than those of mice ventilated with 2% nitrogen. N = 6 for each group. (b) Lung edema caused by VILI was determined by measuring the wet-
to-dry (W/D) ratio. Hydrogen inhalation therapy ameliorated VILI-induced lung edema caused by mechanical ventilation with low TV. N = 6 for
each group. (c) Serum tumor necrosis factor-alpha (TNFa) concentrations were measured after VILI with TV of 10 mL/kg for 5 hours. Hydrogen
treatment significantly reduced VILI-induced elevation of serum TNFa. N = 6. *P < 0.05 versus sham/N2 and sham/H2;
#P < 0.05 versus VILI/N2.
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Figure 7 The effects of hydrogen on ventilator-induced lung injury (VILI)-associated histopathological changes by mechanical
ventilation with low tidal volume (10 mL/kg). (a) Representative images of lungs stained with F4/80 to visualize macrophages. Left panel:
There were few F4/80-positive cells in the lungs of sham control mice. Middle panel: A marked increase in F4/80-postive cells was observed in
the lung with low-tidal volume ventilation. Right panel: Ventilation with 2% hydrogen significantly reduced the number of macrophages.
Magnification = 600 ×. Representative images from four animals for each experimental group are shown. White arrowheads indicate F4/80-
positive cells. (b) Bronchial cell apoptosis was determined by TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate
nick-end labeling) assay. Left panel: Few apoptotic cells were seen in the bronchial epithelium of sham control mice. Middle panel: There was an
increase in the number of TUNEL-positive cells in the bronchial epithelium in the lung with VILI in 2% nitrogen. Right panel: Hydrogen therapy
decreased the number of TUNEL-positive cells. Magnification = 800 ×. Representative images from four animals for each experimental group are
shown. Black arrowheads indicate TUNEL-positive cells. (c) The positive cells were counted in a blinded manner and expressed as the number
per high-power field (HPF). Histograms indicate the number of F4/80-positive cells/HPF and TUNEL-positive epithelial cells/HPF. N = 4. *P < 0.05
versus sham/N2 and sham/H2;
#P < 0.05 versus VILI/N2.
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Additionally, cyclic stretch associated with high-
tidal-volume MV generates ROS and redox imbalance in
lung epithelial and endothelial cells [36]. The antioxi-
dant properties of hydrogen to eliminate ROS may
contribute to the mitigation of VILI in our model.
In our blood gas analyses, there were no significant
differences in PaCO2 levels between animals exposed to
2% nitrogen or 2% hydrogen, although MV for 2 hours
significantly increased PaCO2 levels compared with MV
for 30 minutes. These findings suggest that PaCO2 levels
may not be the best therapeutic indicator in our model,
although PaO2 levels are very sensitive indicators of the
magnitude of VILI. Our ventilation protocol was based
on maintaining PaCO2 in a range of 25 to 35 mm Hg
during the first 30 minutes of the MV period. We
acknowledge the limitations of using PaCO2 as a marker
of VILI in our model; as a marker, PaCO2 would not be
applicable for clinical use and may be influenced by
auto-positive end-expiratory pressure, overdistension, or
atelectasis; however, the PaCO2 changes observed in our
study were likely caused by VILI and not by a poorly
controlled MV setting.
PaCO2 levels can influence inflammation and edema
of the lungs. Hypocapnia increases microvascular per-
meability and impairs alveolar fluid reabsorption, which
may influence the pathogenesis of pulmonary edema
[37]. Furthermore, hypocapnia is directly injurious to
lung parenchyma and worsens ischemia/reperfusion
injury [38]. Therefore, permissive hypercapnia has been
proposed as a protective strategy during MV and contri-
butes to the attenuation of lung inflammatory response
and pulmonary edema [39-42], and the potential exists
for an independent protective/pathological role of altera-
tions in carbon dioxide tension in the context of VILI.
However, the VILI model in this study was designed to
be normocapnic, and our results demonstrated that
higher PaCO2 levels were not associated with less lung
inflammation or edema, suggesting no influence of
PaCO2 levels in our VILI model.
A more comprehensive understanding of the pharma-
cokinetics, biology, and toxicity of hydrogen will cer-
tainly help us harness the protective potential of
hydrogen gas prior to clinical application. Virtually all
patients under ventilation receive oxygen, and, in parti-
cular, patients with pulmonary disease usually require
high levels of oxygen. Although hydrogen, when present
at concentrations of less than 4%, poses no risk of
explosion in air and oxygen, safety is still a concern, and
the desired concentration of hydrogen must be legiti-
mately monitored and maintained with commercially
available tools. In this study, no adverse events related
to hydrogen were observed. We acknowledge that this
experimental model, like most animal models, does not
recapitulate all aspects of clinical VILI. However, it is a
scientifically sound study using a model appropriate to
address the hypothesis. These findings will serve as a
springboard to further translational research. Although
extensive studies on toxicity and safety are needed,
hydrogen treatment of ventilated patients may be clini-
cally feasible and would be easy to incorporate without
alteration of interventional and surgical procedures.
Conclusions
This study demonstrated a novel anti-inflammatory,
antioxidative, and antiapoptotic function of hydrogen
that ameliorated MV-induced lung injury.
Key messages
• Hydrogen inhalation therapy at a safe concentra-
tion mitigated ventilator-induced lung injury in
mice.
• Hydrogen inhalation demonstrated potent antioxi-
dant and anti-inflammatory effects in a mouse venti-
lator-induced lung injury model.
• Hydrogen reduced ventilation-induced epithelial
apoptosis by induction of antiapoptotic genes.
• Adjunctive therapy with inhaled therapeutic medi-
cal gas is promising and might be reasonable for
lung disease as it would be an easily delivered and
straightforward therapeutic option.
• Hydrogen treatment of ventilated patients may
potentially yield a novel, clinically feasible therapy
that would be easy to incorporate without alteration
of interventional and surgical procedures.
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